EV-RNAs show promise for IBD diagnosis and treatment
A research team led by Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine, has published a comprehensive…
Targeted diet helps reprogram aggressive neuroblastoma in mice
A new commentary spotlights preclinical evidence that blocking key amino acids, along with a polyamine-blocking drug, may force…
Mayo Clinic researchers develop experimental nanotherapy to treat aggressive brain tumors
Mayo Clinic researchers developed an experimental nanotherapy that delivers two cancer drugs directly to brain tumors, according to…
Scientists turn red blood cells into long-lasting drug and imaging carriers in mice
A new preclinical study shows that red blood cells can be tagged in vivo and used as long-lasting…
New strategy to fight chronic kidney inflammation
Mayo Clinic researchers have identified a drug-and-supplement combination therapy that is capable of reducing the harmful effects of senescent…
Could GLP-1 drugs help curb addiction? Large veteran study points to potential benefit
A major study of US veterans suggests that GLP-1 diabetes medications may influence addiction-related outcomes, revealing a surprising…
New research initiative aims to predict and prevent diseases before they start
What if doctors could tell you a disease was coming years before you felt a single symptom-and stop…
How zinc deficiency could worsen heart inflammation and what that means for patients
New research suggests that zinc does far more than support immunity, revealing intricate molecular switches that may influence…
Researchers reveal why SuperAgers retain youthful brain cell signatures into their 80s
A multiomic atlas of the aging human hippocampus uncovers how epigenetic regulation of neural stem cells and immature…
Study identifies PPP2R5C blood marker that may detect Alzheimer’s disease earlier
Researchers report that declining PPP2R5C levels in blood may signal early Alzheimer’s pathology, offering new insight into tau…
Remote-controlled CAR T cells offer safer cancer therapy
Among the most promising tools of cancer therapy, engineered immune cells known as chimeric antigen-receptor (CAR) T cells…
Alzheimer’s plaques decline after CAR-T immune cell treatment in preclinical study
A novel CAR-T cell approach targets amyloid plaques in preclinical Alzheimer models, raising the possibility that engineered immune…